Thank you for subscribing!
Next Investors Archived May 05, 2020
OncoSil Medical (ASX:OSL) has received CE Mark approval to market and sell its breakthrough implantable radiotherapy treatment for pancreatic cancer in the EU and UK.
Finfeed Archived Apr 20, 2020
PharmAust Ltd’s (ASX: PAA) wholly owned subsidiary Epichem has produced its first batch of chemistry grade hand sanitiser.
Get expert stock analysis direct in your inbox
Join Our Mailing List
